SCHEMBL6223253

SCHEMBL6223253

O=C(NCC1CCCCN1)Nc1cccc(F)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.55
RAB9A P51151 4/20 0.55
NPC1 O15118 3/20 0.55
MEN1 O00255 3/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
EPHX1 P07099 3/20 0.49
EPHX2 P34913 2/20 0.49
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
OPRK1 P41145 1/20 0.48
POLB P06746 1/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
MTOR P42345 1/20 0.46
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
GRM5 P41594 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6220913 0.85 RAB9A (0.51) KMT2ARAB9ANPC1MEN1EPHX1
SCHEMBL6223250 0.85 RAB9A (0.51) KMT2ARAB9ANPC1MEN1EPHX1
SCHEMBL6222283 0.85 EPHX1 (0.63) RAB9ASMN1; SMN2EPHX1EPHX2OPRM1
SCHEMBL6222279 0.85 EPHX1 (0.63) RAB9ASMN1; SMN2EPHX1EPHX2OPRM1
SCHEMBL8290068 0.81 OPRM1 (0.65) KMT2ARAB9ANPC1MEN1SMN1; SMN2
SCHEMBL20344071 0.81 CYP1A2 (0.58) KMT2AMEN1GAASMN1; SMN2OPRM1
Hydrochloric Acid SCHEMBL4743581 0.80 OPRM1 (0.64) KMT2ARAB9ANPC1MEN1SMN1; SMN2
SCHEMBL6779282 0.79 CCR3 (0.66) KMT2AMEN1
SCHEMBL6774155 0.79 CCR3 (0.62) KMT2APOLBLMNA
SCHEMBL7682490 0.79 CCR3 (0.66) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289955-B1 PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2005-04-13 EP disclosed
US-6677354-B2 TREATING SLEEP, BRAIN, SEXUAL, CARDIOVASCULAR, NERVOUS SYSTEM, PSYCHOLOGICAL, GLANDULAR, AND GASTROINTESTINAL DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2004-01-13 US disclosed
EP-1289955-A1 PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-03-12 EP disclosed
WO-2001096302-A1 PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM P.L.C. (GB) 2001-12-20 WO disclosed